Public offerings often lead to dilution of existing shares, which can negatively impact the stock price as the market anticipates a greater supply of shares. The direct mention of bluebird bio and the specific financial action of a public offering make this news highly relevant and important to the company's stock. The confidence in the analysis is high due to the typical market reaction to such announcements, although market conditions and investor sentiment can also influence the actual impact.